NKT THERAPEUTICS

nkt-therapeutics-logo

NKT Therapeutics is a privately held biotechnology company focused on developing therapeutics based on unique immune cells called natural killer T (NKT) cells. The company's mission is to use its expertise to develop a pipeline of first-in-class NKT-based therapeutics to treat cancer, infectious diseases, autoimmune diseases, asthma and dermatitis.

#SimilarOrganizations #People #Financial #Website #More

NKT THERAPEUTICS

Industry:
Biotechnology Health Care Therapeutics

Founded:
2008-01-01

Address:
Waltham, Massachusetts, United States

Country:
United States

Website Url:
http://www.nktrx.com

Total Employee:
1+

Status:
Active

Contact:
6174541009

Email Addresses:
[email protected]

Total Funding:
12 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Content Delivery Network Nginx Sectigo SSL Sectigo Domain SSL UNPKG ENom DNS Intermedia


Similar Organizations

not_available_image

Georgiamune

Georgiamune is a biotechnology company developing next-generation immunotherapeutics for cancer and autoimmune diseases.

keren-therapeutics-logo

Keren Therapeutics

Keren Therapeutics is harnessing the biology of a naturally occurring peptide hormone to restore muscle function.

novelmed-therapeutics-logo

NovelMed Therapeutics

NovelMed Therapeutics is a biotechnology company developing novel therapies for orphan and non-orphan diseases.

paramita-therapeutics-logo

Paramita Therapeutics

Paramita Therapeutics is a biotech company that focuses on developing new cancer and infectious disease therapeutics.


Current Advisors List

peter-kiener_image

Peter Kiener Scientific Advisory Boards @ NKT Therapeutics
Advisor

Current Employees Featured

not_available_image

Barbara Finck
Barbara Finck CMO @ NKT Therapeutics
CMO

Founder


mark-tepper_image

Mark Tepper

Investors List

sv-life-sciences_image

SV Health Investors

SV Health Investors investment in Venture Round - NKT Therapeutics

medimmune-ventures_image

MedImmune Ventures

MedImmune Ventures investment in Series A - NKT Therapeutics

sv-life-sciences_image

SV Health Investors

SV Health Investors investment in Series A - NKT Therapeutics

Official Site Inspections

http://www.nktrx.com

  • Host name: app.wf.carrierzone.com
  • IP address: 216.55.155.33
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "NKT Therapeutics" on Search Engine